Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial.
about
A review of anti-inflammatory agents for symptoms of schizophreniaCelecoxib for schizophreniaRisperidone versus placebo for schizophreniaOsteoprotegerin levels in patients with severe mental disordersInflammatory cytokines and neurological and neurocognitive alterations in the course of schizophreniaCelecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On TrialsInflammation and immunity in schizophrenia: implications for pathophysiology and treatmentThe cytokine model of schizophrenia: emerging therapeutic strategiesPostmortem evidence of cerebral inflammation in schizophrenia: a systematic reviewEfficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an updateMeta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effectsViral infection, inflammation and schizophreniaThe Application of Multiplex Biomarker Techniques for Improved Stratification and Treatment of Schizophrenia Patients.Application of Proteomic Techniques for Improved Stratification and Treatment of Schizophrenia Patients.Immunological aspects of the treatment of depression and schizophrenia.Analysis of peripheral immune activation in schizophrenia using quantitative reverse-transcription polymerase chain reaction (RT-PCR)Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume.The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder.Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review.Immune System and SchizophreniaCognition, dopamine and bioactive lipids in schizophrenia.Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA.Celecoxib: a new augmentation strategy for depressive mood episodes. A systematic review and meta-analysis of randomized placebo-controlled trials.Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?Soluble urokinase-type plasminogen activator receptor levels in patients with schizophreniaA triple-blinded, randomized, placebo-controlled trial to examine the efficacy of buspirone added to typical antipsychotic drugs in patients with chronic schizophrenia.Morphological features of microglial cells in the hippocampal dentate gyrus of Gunn rat: a possible schizophrenia animal modelDifferential age- and disease-related effects on the expression of genes related to the arachidonic acid signaling pathway in schizophreniaInflammatory markers in antipsychotic-naïve patients with nonaffective psychosis and deficit vs. nondeficit features.Is there a role for immune-to-brain communication in schizophrenia?Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?Eicosanoids Derived From Arachidonic Acid and Their Family Prostaglandins and Cyclooxygenase in Psychiatric DisordersFuture perspectives on the treatment of cognitive deficits and negative symptoms in schizophrenia.Does Systemic Inflammation Play a Role in Pediatric Psychosis?Proteomic profiling in schizophrenia: enabling stratification for more effective treatment.Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trialsMeta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects.Cytokines and schizophrenia: Microglia hypothesis of schizophrenia.Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy.
P2860
Q22241827-5B3ABAC2-F063-443E-B7FE-A47B18F01EAFQ24235746-121B8A58-15F7-48D0-97CB-708F4FC8E0ABQ24241041-9B159AEB-DA1F-4C40-B2D3-853633916E94Q24626094-820ED07C-8362-4815-9B4F-25EE4FDAF221Q24630651-9AA8748E-3442-45A6-AC99-FA7D8B0A81C8Q26741541-DE0F7BE3-40F6-431B-9912-DC816B619359Q26781620-A0E905CB-355D-40C9-A941-08B08DAE389CQ26865996-3B93B684-9604-43D0-B530-080075D3E0E0Q28077391-C61E4D02-FC51-4573-B38E-454CEA3FCCD4Q28299995-401D6732-B489-46B1-9D2E-66590ED7547EQ28657600-3470DF1D-9AC8-441F-9B9B-765D0195A092Q30440507-814672CA-7638-477C-8872-5CF1E5F6EB38Q33451672-599113DB-5900-4FF9-89D9-CE272032A37DQ33453744-BAE9BA03-CDEE-4160-8874-9A8F985ECD56Q33721031-477411BB-3F36-44BC-A75C-911E6DE5CFFEQ33749249-32DFB047-0949-4F9C-91F7-B59D98C707E4Q33849008-EAE0A1F9-0E48-443C-8051-4DBC443D6075Q34088944-796A543D-556E-4DE7-AC53-CDF68931B4C5Q34274859-B93927D2-4E8E-4096-B24A-3C17460B1103Q34384181-8C6BD397-D838-4C34-BC6B-5729601933C4Q34625031-25986890-5628-46AE-A0BA-37F750FC11BAQ34699360-3CD421B3-3B0D-4C8C-A33F-C25E4C4AE759Q34701163-18C1B73A-0812-44B5-A484-9A42D3B2E763Q35184044-CD665365-602B-4012-BBD2-835F4D1FC5EBQ35225947-7C63FD1B-7BB9-42B5-A4FD-FE473E38452AQ35369617-47BB5DD2-91C7-4590-AE56-70FD8FC0A774Q35454624-DEAB1B4C-9C3B-4F47-914B-8D78E35FC109Q35907956-1793A262-28E8-4157-AF0C-AB851ABFA290Q35992194-02617F18-8AD5-4796-9406-D51D42FC8A2BQ36031032-D36A87D6-0547-4A06-8434-D688E5570826Q36351021-0D4EBA00-BBFC-404F-9BA6-7B08072062DEQ36502629-1B6821DF-8972-4F0F-9896-2DC4E1FD09F6Q36594940-74D0BE6D-CCC9-41AF-A106-9F7ABE0C31FEQ36930839-3443173D-C4E3-400D-B50D-F575DEDC3B9AQ36986370-4C473933-9E2D-483F-A658-74C0A414284CQ36998471-E500874A-837F-40E7-9A7D-15AC0DFA7B48Q37228346-C7E740B4-714D-4839-9A7D-718F1ECE001FQ37275549-D137FC19-CD52-415F-AB23-1DCFDD045A78Q37541981-9A393147-8834-450D-9FF7-5382B4681C17Q37546096-80C7E4C1-EC20-447B-9832-81D263B2B0E1
P2860
Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Celecoxib as adjunctive therap ...... and placebo-controlled trial.
@en
Celecoxib as adjunctive therap ...... and placebo-controlled trial.
@nl
type
label
Celecoxib as adjunctive therap ...... and placebo-controlled trial.
@en
Celecoxib as adjunctive therap ...... and placebo-controlled trial.
@nl
prefLabel
Celecoxib as adjunctive therap ...... and placebo-controlled trial.
@en
Celecoxib as adjunctive therap ...... and placebo-controlled trial.
@nl
P2093
P1476
Celecoxib as adjunctive therap ...... and placebo-controlled trial.
@en
P2093
Behnaz Behnam
Homayoun Amini
Maryam Tabatabaee
Seyed Ali Ahmadi Abhari
Seyed Hesamedin Abbasi
P304
P356
10.1016/J.SCHRES.2006.11.016
P407
P577
2007-01-08T00:00:00Z